HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?
about
Stranger in a strange landNatural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor ActivityLung cancer: a classic example of tumor escape and progression while providing opportunities for immunological interventionThe dual role of HLA-G in cancerRole of non-classical MHC class I molecules in cancer immunosuppressionAssociation of theHLA-G3′UTR polymorphisms with colorectal cancer in Italy: a first insightNon-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis.Serum soluble HLA-E in melanoma: a new potential immune-related marker in cancer.Low expression of human histocompatibility soluble leukocyte antigen-G (HLA-G5) in invasive cervical cancer with and without metastasis, associated with papilloma virus (HPV).Generation of recombinant antibody fragments that target canine dendritic cells by phage display technology.Soluble HLA-G expression and renal graft acceptance.The role of HLA-G in immunity and hematopoiesis.BRAF V600E in papillary thyroid carcinoma is associated with increased programmed death ligand 1 expression and suppressive immune cell infiltration.The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis.Unfavourable clinical implications for HLA-G expression in acute myeloid leukaemia.Application of human leukocyte antigen-G expression in the diagnosis of human cancerExpression of human leukocyte antigen G is associated with prognosis in nasopharyngeal carcinoma.Amniotic fluid soluble human leukocyte antigen-G in term and preterm parturition, and intra-amniotic infection/inflammationBiology of HLA-G in cancer: a candidate molecule for therapeutic intervention?Identification of a novel HLA-G+ regulatory population in blood: expansion after allogeneic transplantation and de novo HLA-G expression at graft-versus-host disease sitesClinical and biological significance of HLA-G expression in ovarian cancerSoluble HLA-G: Are they clinically relevant?Human leukocyte antigen-G is frequently expressed in glioblastoma and may be induced in vitro by combined 5-aza-2'-deoxycytidine and interferon-γ treatments: results from a multicentric study.Epigenetic changes within the promoter region of the HLA-G gene in ovarian tumors.A distant trophoblast-specific enhancer controls HLA-G expression at the maternal-fetal interface.Non-classical major histocompatibility complex proteins as determinants of tumour immunosurveillance.A commentary on gestational programming and functions of HLA-G in pregnancyNK cells and cancer immunosurveillance.Clinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer.Aberrant human leucocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma.Human leukocyte antigen class I expression is an independent prognostic factor in advanced ovarian cancer resistant to first-line platinum chemotherapy.Expression and function of immunoglobulin-like transcripts on tolerogenic dendritic cells.Inhibition of host immune response in colorectal cancer: human leukocyte antigen-G and beyond.Serum and peritoneal fluid concentrations of soluble human leukocyte antigen, tumor necrosis factor alpha and interleukin 10 in patients with selected ovarian pathologies.Natural killer cells and malignant haemopathies: a model for the interaction of cancer with innate immunity.HLA-G expression in hematologic malignancies.Nanoparticles targeting HLA-G for gene therapy in cancer.How tumors might withstand γδ T-cell attack.New insights into HLA-G mediated tolerance.microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer.
P2860
Q24671903-B9C854AF-9A48-4AB7-B409-09EA0D6979ACQ26773135-A2743F82-22DD-4DC6-8496-415454F57563Q26850218-EC9A5243-7393-4936-9B8C-F0E83DC773D9Q26860886-A6EE94B5-73CE-4F56-9046-7374EB68442AQ26999722-DCB33466-2B7C-4222-B366-DAE696FDBE36Q29030926-01E411A6-C73E-433E-A898-761E434F42E4Q30315505-DEB73E8D-0148-4B01-B7C9-CB2F61C6A620Q31021595-A39EE04E-5B9E-4A56-B4DD-CD0A8D775DF3Q33803141-DA787966-C0AD-43CF-BBA3-7B7E06505CD2Q33994982-FC9B8641-7C27-4557-9E58-18CD87DB2E0AQ33996904-7899537E-24A5-4B36-8CEC-FF3FA0147630Q34024865-83354A00-F5AE-43B7-800E-51F6BDF6D8A0Q34103836-BABEE70E-7472-4C5F-82AC-BF4BB7CFCBEEQ35079738-5C9DEF65-CD47-441F-A9E6-D1F05BFA5831Q35458400-E7432146-4BA5-4799-818F-87C1DDB8AE63Q35867466-ADB92E34-79FA-4BE3-BA2A-9A7E89D178BFQ36063731-41D41DCB-EE56-472B-99A1-961E4D802CC9Q36179791-FB174F00-9F83-42DB-A5DC-3E2ED8CA808FQ36184793-03D86689-0621-4855-8711-CAC3921B27F3Q36216198-435AA16A-232D-45DA-9646-2F5A7AD600A1Q36296442-2C97A89C-D300-45B8-AE86-6EE69458234AQ36384011-6E2F5C8A-161A-486F-93D6-7E26F2A8FDF8Q36582874-9AF715B0-06D9-4538-9F6E-702D764860CAQ36724467-4B0FB15D-5F81-41D8-A972-42C5012D7F68Q36905039-F9542CC4-6A07-4D77-BA8C-C52D9E955BFBQ36986947-12285DF5-3C21-4C44-B479-7A08998BD42BQ37257854-E1A534EE-66F7-47D4-972B-3228D0090AF9Q37287176-C64C78F4-9F95-410D-A36E-9272B0FEC968Q37293938-6D101867-436D-4F84-AA8D-BE26AF0318D9Q37294991-EDF03999-BC85-48A5-8830-D0D6741FE986Q37401538-C9835E7C-BA9E-46F8-B532-8D8320B3DDF7Q37417083-915C11D7-5D19-41B3-8CE3-F1C135122DE8Q37697529-9F3F5E4D-B3CF-411A-8973-7924DFC2AC92Q37738040-399D53A8-E4B1-4037-A114-3250C05FB4DBQ37779043-4AC788BF-40DA-4F7F-9710-CCB169FF814DQ37810072-ACE12BF8-C403-4B04-8979-D30A030FEE80Q37866158-8952FE18-CF7E-4566-9309-FC9D427002C1Q37872644-120EE7D5-432A-4271-944F-4107BDC210DBQ38240763-65A87CA7-B335-4AB4-B72C-7059C1B7E1DBQ38336073-3D2633DA-0076-4185-8AF7-FE472FE2DF5D
P2860
HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?
@ast
HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?
@en
type
label
HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?
@ast
HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?
@en
prefLabel
HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?
@ast
HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?
@en
P2093
P1433
P1476
HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?
@en
P2093
Edgardo D Carosella
Nathalie Rouas-Freiss
Philippe Moreau
Soldano Ferrone
P304
10139-10144
P356
10.1158/0008-5472.CAN-05-0097
P407
P577
2005-11-01T00:00:00Z